Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,762
datasets available to search
ShareScore release 0.9.0
Dataset results
3,762 results for “Combination treatment”
A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07142421. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07383116. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection
ClinicalTrials.gov study NCT03794258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
ClinicalTrials.gov study NCT00120835. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection
ClinicalTrials.gov study NCT06644417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold
ClinicalTrials.gov study NCT05070650. IPD Sharing: YES. Countries: 0. Publications: 0.
A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy
ClinicalTrials.gov study NCT05511051. IPD Sharing: NO. Countries: 1. Publications: 0.
Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis
ClinicalTrials.gov study NCT06833112. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
ClinicalTrials.gov study NCT03983928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma
ClinicalTrials.gov study NCT04156828. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT04985136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
ClinicalTrials.gov study NCT03224221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer
ClinicalTrials.gov study NCT05035914. IPD Sharing: NO. Countries: 1. Publications: 0.
Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma （HNC-SYSU-005）
ClinicalTrials.gov study NCT07267286. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas
ClinicalTrials.gov study NCT04253873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
ClinicalTrials.gov study NCT05353673. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05507541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT05448183. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparison of the Effect of Combined Glenohumeral Joint and Subdeltoid Bursa Injection With Platelet-rich Plasma (PRP), Corticosteroid, and Normal Saline in Addition to Physical Therapy for Treatment
ClinicalTrials.gov study NCT05230667. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC
ClinicalTrials.gov study NCT05143099. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.